DefinedHealth

Insight Briefings

Insight Series

Invitation-only strategic briefings on the future of various therapeutic categories for senior executives in pharma, biotech and healthcare investing.

To view or download a presentation, simply click on the PDF icon shown below. If you need technical assistance with our presentations please email Javier A. Mayorga at jmayorga@definedhealth.com.

Frailty: Growth Opportunities for Senescing Pharma Franchises?

March 22nd, 2010
Basking Ridge, NJ

New Therapies for Diabetes: Getting to the Heart of the Matter

January 19th, 2010
Basking Ridge, NJ

Alzheimer’s Disease: Moving Forward or Spinning our Wheels?

November 24th, 2009
Basking Ridge, NJ
Basel, Switzerland

Shifting Cancer Care to Chemoprevention: Can We Ever Move to a Model of Treating Risk?

September 30th, 2009
Basking Ridge, NJ
Basel, Switzerland

On a Dime in Very Little Time: Biotech’s New Value Creation Challenge

June 23rd, 2009

Biologics Have Come of Age

February 11th, 2009
Basking Ridge, New Jersey / Basel, Switzerland

Game Changing Plays in the Pain Market

January 8th, 2009

Frailty: Growth Opportunities for Senescing Pharma Franchises?

December 11th, 2008
Basking Ridge, NJ Burlingame, CA

Getting Beyond Prevention: Inventive Strategies for COPD

October 30th, 2008
Basking Ridge, NJ Basel, Switzerland

The Next Oncology Blockbuster - Innovation Drift or Paradigm Shift?

September 16th, 2008
Basking Ridge, NJ

Supportive Neurology: QoL for Patients with Neurological and Neuro-Psychiatric Disorders

March 12th, 2008
Basking Ridge, NJ

Antimicrobials: Will Pharma Overcome Its Resistance?

February 26th, 2008
Basking Ridge, NJ

Cardiovascular Franchises: Too Much Risk in Prevention?

February 13th, 2008
Basking Ridge, NJ

Orphan Drugs: Will they be Fostered by Biotech Alone?

January 16th, 2008
Basking Ridge, NJ

Therapeutic Vaccines: Salvage or Salvation? Will Therapeutic Vaccines be a Last Resort or an Alternative to Conventional Therapies?

November 29th, 2007
Basking Ridge, NJ

The Evolving Oncology Market: Finding a Safe Harbor or Bracing for a Sea Change?

September 10th, 2007
Basking Ridge, NJ

The New Realities of Financing Drug Discovery: Implications for Pharma and Biotech M&A and Licensing Relationships

May 24th, 2007
Cambridge, United Kingdom

The New Realities of Financing Drug Discovery: Implications for Pharma and Biotech M&A and Licensing Relationships

May 22nd, 2007
Basel, Switzerland

Getting Personal and Getting Past It: Moving Beyond Individualized Therapies in Cancer to “Less Impersonal” Medicine in Non-Oncology Indications

March 27th, 2007
Basking Ridge, NJ

Repurposing, Translational Medicine and other Strategies for De-Risking CNS

February 27th, 2007
Basking Ridge, NJ

HDL Therapeutics in the Wake of Torcetrapib

January 27th, 2007
Basking Ridge, NJ

The Dermatology Enigma: Exploring the Disconnect Between Unmet Needs and Pharma Investment

November 29th, 2006
Basking Ridge, NJ

Male & Female Sexual Dysfunction Beyond ED: Does Pharma Have a Future in the Bedroom?

October 26th, 2006
Basking Ridge, NJ

Complex Therapies Redux: Therapeutic Vaccines, Cell and Gene

March 30th, 2006
Basking Ridge, NJ

Neuropathic Pain: A New Frontier

March 1st, 2006
Basking Ridge, NJ

Obesity: Getting the Skinny on a Big Market

January 31st, 2006
Basking Ridge, NJ

Spotlight on Ophthalmology: Is It All About AMD?

November 17th, 2005
Morristown, NJ

Oncology: Pharmacogenetics is Not Just for Targeted Therapies - Making Intelligent Space for Chemotherapy in the 21st Century

October 6th, 2005
Morristown, NJ

Complex Therapeutics: Therapeutic Vaccines, Cell and Gene Therapy Will Pharma “Deliver” When the Product is Not Off-the-Shelf?

February 24th, 2005
Morristown, NJ

Rethinking Opportunity Risk in Neurodegeneration: New Pathways to Treatment

January 21st, 2005
Morristown, NJ

Browse the Presentations by Category:

Feeding the Pipeline

Industry Presentations

Browse the Presentations by Year: